Del. Justices Uphold $275M AstraZeneca Drug Trial Debt Toss
By Jeff Montgomery ( October 21, 2021, 7:50 PM EDT) -- Delaware's Supreme Court on Thursday upheld without elaboration a Chancery Court finding that cleared AstraZeneca PLC of liability for $275 million in post-merger cancer drug development "milestone" payments to investors in biopharmaceutical company Amplimmune LLC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.